CPIX

$4.31+2.13%visit website

CUMBERLAND PHARMACEUTICALS INC

Market Cap

$65M

Live price × SEC shares (Aug 5, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.13

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

1.6

TTM to Jun 2026 · revenue

Flagged input, hover for details

P/B

3.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2025 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	8,292	13,679	9,131	8,801	39,904
Cost of revenue	989	2,241	1,934
Research & development	1,253	1,550	1,458	772	5,034
Operating income	(1,965)	(1,371)	(3,129)	(3,160)	(9,626)
Interest expense	110	113	86	1	309
Pretax income	(1,943)		(3,137)	(3,100)
Income tax	5.7	23.2	3.9	3.9	36.7
Net income	(1,941)	(1,412)	(3,290)	(4,276)	(10,918)
EPS (basic) ($)	(0.13)	(0.09)	(0.22)	(0.29)	(0.73)
EPS (diluted) ($)	(0.13)	(0.09)	(0.22)	(0.29)	(0.73)
Weighted avg. shares (basic)	14,959		14,960	14,982
Weighted avg. shares (diluted)	14,959		14,960	14,982

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 7, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

15 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 26, 2026 accepted 4:40 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Oct 23, 2026 accepted 5:01 PM ET	8.01Other events	Document SEC ↗
Sep 11, 2026 accepted 4:51 PM ET	8-K/A 5.07Shareholder vote	Document SEC ↗
Aug 28, 2026 accepted 5:08 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 4, 2026 accepted 5:20 PM ET	2.02Earnings release	Document SEC ↗
Jul 13, 2026 accepted 5:28 PM ET	8.01Other events	Document SEC ↗
Jul 1, 2026 accepted 4:15 PM ET	1.01Material agreement1.02Agreement terminated2.01Acquisition / disposition5.02Officer / director change8.01Other events	Document SEC ↗
Jun 25, 2026 accepted 5:00 PM ET	5.07Shareholder vote	Document SEC ↗
May 5, 2026 accepted 5:07 PM ET	2.02Earnings release	Document SEC ↗
Apr 24, 2026 accepted 5:08 PM ET	5.07Shareholder vote	Document SEC ↗